Evelyn De Tavernier

2 Patents

• US120984002024

  Highly Potent ISVD Compounds Capable of Substituting for FVIII(A)

  Novo Nordisk A/S

  0 cites
• US117878742023

  Factor X Binders Enhancing FX Activation

  Novo Nordisk A/S

  0 cites